Misty D Smith Selected Research

Misty D Smith Research Topics

Disease

15	Seizures (Absence Seizure) 01/2022 - 01/2007
13	Epilepsy (Aura) 01/2022 - 01/2007
7	Pain (Aches) 01/2019 - 02/2013
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 02/2007
4	Drug Resistant Epilepsy 09/2019 - 01/2007
3	Temporal Lobe Epilepsy 01/2022 - 05/2007
3	Cognitive Dysfunction 07/2017 - 04/2014
2	Infections 01/2022 - 09/2019
2	Neoplasms (Cancer) 01/2019 - 01/2015
2	Neuralgia (Stump Neuralgia) 07/2017 - 01/2017
2	Acute Pain 01/2015 - 01/2015
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021
1	Central Nervous System Infections (Central Nervous System Infection) 09/2019
1	Virus Diseases (Viral Diseases) 09/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Edema (Dropsy) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Hyperglycemia 07/2017
1	Hyperalgesia 07/2017
1	Tobacco Use Disorder (Nicotine Dependence) 01/2016
1	Memory Disorders (Memory Loss) 07/2015
1	Schizophrenia (Dementia Praecox) 01/2015
1	Sclerosis 04/2014
1	Disease Progression 04/2014
1	Inflammation (Inflammations) 04/2011
1	Dehydration (Water Stress) 04/2011

Drug/Important Bio-Agent (IBA)

6	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2007
5	GalaninIBA 01/2019 - 12/2008
5	NeuropeptidesIBA 01/2016 - 12/2008
4	CarrageenanIBA 01/2019 - 02/2013
4	Formaldehyde (Formol)FDA Link 07/2017 - 02/2013
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 01/2017
3	Kainic Acid (Kainate)IBA 01/2022 - 05/2007
3	CannabidiolIBA 09/2019 - 07/2017
3	Analgesics (Analgesic Drugs)IBA 01/2019 - 01/2015
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 01/2017
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2022 - 01/2017
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2022 - 03/2007
2	Galanin Receptors (Galanin Receptor)IBA 07/2017 - 01/2015
2	Nicotine FDA Link 01/2016 - 07/2015
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2012 - 06/2012
1	Tiagabine (Gabitril)FDA Link 01/2022
1	ezogabine (retigabine)IBA 01/2022
1	Topiramate (Topamax)FDA LinkGeneric 01/2022
1	Lacosamide FDA Link 01/2022
1	BenzodiazepinesIBA 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2019
1	NAX 5055IBA 01/2019
1	Excitatory Amino Acid AntagonistsIBA 11/2018
1	NAX 810-2IBA 07/2017
1	Antidepressive Agents (Antidepressants)IBA 07/2017
1	Growth Hormone (Somatotropin)IBA 07/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2017
1	Insulin (Novolin)FDA Link 07/2017
1	Pentylenetetrazole (Metrazol)IBA 07/2017
1	sec-butyl-propylacetamideIBA 01/2017
1	AmidesIBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2016
1	Cholinergic Agents (Cholinergics)IBA 07/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2015
1	Methamphetamine (Desoxyn)FDA LinkGeneric 07/2015
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2015
1	cresyl violetIBA 04/2014
1	salicylhydroxamic acid (SHAM)IBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	Neuropeptide YIBA 01/2013
1	S(8)IBA 06/2012
1	Transcription Factors (Transcription Factor)IBA 04/2011
1	Betaine (C.B.B.)FDA Link 04/2011
1	Messenger RNA (mRNA)IBA 04/2011
1	GABA Plasma Membrane Transport ProteinsIBA 04/2011
1	NFATC Transcription FactorsIBA 04/2011
1	LipopolysaccharidesIBA 04/2011
1	NeurotensinIBA 03/2009
1	SodiumIBA 03/2007
1	Sodium Channels (Sodium Channel)IBA 02/2007
1	General AnestheticsIBA 02/2007
1	Propofol (Diprivan)FDA LinkGeneric 02/2007

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2007
3	Analgesia 01/2019 - 02/2013
3	Ligation 07/2017 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2019 - 07/2017
2	Polypharmacy 01/2018 - 01/2017
1	Induced Hyperthermia (Thermotherapy) 01/2021
1	Intraperitoneal Injections 01/2021
1	Investigational Therapies (Experimental Therapy) 07/2017